Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Philip Morris International Inc. (PM) Earnings: An Early Look

Earnings season is in full swing, with huge numbers of companies having already given their latest numbers to investors. The key to making smart investment decisions with stocks releasing their quarter reports is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you’ll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.

Philip Morris International Inc. (NYSE:PM)

Let’s turn to Philip Morris International Inc. (NYSE:PM). The cigarette giant has taken the power of its Marlboro brand across the world, capitalizing on a growing consumer class in emerging markets. Let’s take an early look at what’s been happening with Philip Morris over the past quarter and what we’re likely to see in its quarterly report on Thursday.

Stats on Philip Morris International Inc. (NYSE:PM)

Analyst EPS Estimate $1.22
Change From Year-Ago EPS 10.9%
Revenue Estimate $8.03 billion
Change From Year-Ago Revenue 4.7%
Earnings Beats in Past 4 Quarters 3

Source: Yahoo! Finance.

Will Philip Morris keep smoking higher?
Analysts have barely budged on their opinions on Philip Morris, cutting their earnings-per-share estimate on the stock by a single penny over the past three months. Shareholders have been equally muted in their enthusiasm, with the share price rising less than 2% since early November.

The bullish argument for Philip Morris is essentially the same one on which it and former parent Altria Group, Inc. (NYSE:MO) have executed successfully for decades. The company’s impressive dividend yield, strong payout growth over time, and substantial buybacks all make the stock attractive to investors. Moreover, with emerging markets pulling in far more growth than the U.S. market, Philip Morris is avoiding many of the headwinds that domestically focused Altria, Lorillard Inc. (NYSE:LO) , and Reynolds American, Inc. (NYSE:RAI) have had to deal with, including greater regulation and negative ad campaigns.

Yet Philip Morris hasn’t gotten off scot-free on the regulatory front, as countries around the world start to follow the lead of U.S. regulators and impose their own restrictions on the company. Australia’s cigarette-packaging policies have gotten the lion’s share of attention so far, but you’ll find similar pressures in several other countries to try to rein in tobacco companies in light of health concerns.

One thing investors need to look at in assessing Philip Morris’ earnings is the relationship between earnings and dividend payments. With its payout ratio approaching 70%, Philip Morris needs to keep boosting earnings in order to support its attractive dividend policy. Given how comfortable investors have gotten with massive dividend growth in recent years, any slowdown in dividend increases could make investors think twice about adding to their positions, especially as multiples have expanded greatly in recent years.

The article Philip Morris Earnings: An Early Look originally appeared on and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool owns shares of Philip Morris International (NYSE:PM).

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!